Ketan R. Bulsara
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Ketan R. Bulsara has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
Gregory A. Kuzmik
Department of Neurosurgery, Yale School of Medicine, New Haven, Connecticut
3 shared publications- David Hasan
Department of Neurosurgery (D.H.), Duke University School of Medicine, Durham, NC
2 shared publications Joshua Pepper
Department of Neurosurgery, Yale School of Medicine, New Haven, Connecticut
2 shared publicationsRyan Grant
Yale Department of Neurosurgery, Neurovascular and Spine Sections, Yale University School of Medicine, New Haven, Connecticut, USA
2 shared publicationsA.O. Vortmeyer
Department of Pathology, Yale School of Medicine, New Haven CT 06510, United States
1 shared publicationA.R. Patel
University of Texas Southwestern Medical Center, Dallas TX 75390, United States
1 shared publication
Latest Publications
- 22 August 2017
- Published by Springer Nature
- p. 117-136
Mechanical Thrombectomy for Acute Ischemic Stroke
- 22 August 2017
- Published by Springer Nature
- p. 117-136
Mechanical Thrombectomy for Acute Ischemic Stroke
- 26 June 2017
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 380, 51-53
Suspected retroorbital inflammation resulting in bilateral occlusion of the internal carotid arteries
- 26 June 2017
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 380, 51-53
Suspected retroorbital inflammation resulting in bilateral occlusion of the internal carotid arteries
- 1 January 2017
- Published by Elsevier in World Neurosurgery
- Vol. 97, 749.e21-749.e26
Spinal Dural Arteriovenous Fistulas with Segmental Arterial Supply Also Giving Rise to a Radiculomedullary Artery: A Case Report and Review of the Literature
- 1 January 2017
- Published by Elsevier in World Neurosurgery
- Vol. 97, 749.e21-749.e26
Spinal Dural Arteriovenous Fistulas with Segmental Arterial Supply Also Giving Rise to a Radiculomedullary Artery: A Case Report and Review of the Literature
- 1 July 2015
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 36 (4) , 583-586
Bilateral osteomas and exostoses of the internal auditory canal
- 1 July 2015
- Published by Elsevier in American Journal of Otolaryngology
- Vol. 36 (4) , 583-586
Bilateral osteomas and exostoses of the internal auditory canal
- Open Access
- 28 October 2014
- Published by Hindawi Limited in The Scientific World Journal
- Vol. 2014, 1-7
Hemifacial Spasm and Neurovascular Compression
Hemifacial spasm (HFS) is characterized by involuntary unilateral contractions of the muscles innervated by the ipsilateral facial nerve, usually starting around the eyes before progressing inferiorly to the cheek, mouth, and neck. Its prevalence is 9.8 per 100,000 persons with an average age of onset of 44 years. The accepted pathophysiology of HFS suggests that it is a disease process of the nerve root entry zone of the facial nerve. HFS can be divided into two types: primary and secondary. Primary HFS is triggered by vascular compression whereas secondary HFS comprises all other causes of facial nerve damage. Clinical examination and imaging modalities such as electromyography (EMG) and magnetic resonance imaging (MRI) are useful to differentiate HFS from other facial movement disorders and for intraoperative planning. The standard medical management for HFS is botulinum neurotoxin (BoNT) injections, which provides low-risk but limited symptomatic relief. The only curative treatment for HFS is microvascular decompression (MVD), a surgical intervention that provides lasting symptomatic relief by reducing compression of the facial nerve root. With a low rate of complications such as hearing loss, MVD remains the treatment of choice for HFS patients as intraoperative technique and monitoring continue to improve.
- 28 October 2014
- Published by Hindawi Limited in The Scientific World Journal
- Vol. 2014, 1-7
Open AccessHemifacial Spasm and Neurovascular Compression
Hemifacial spasm (HFS) is characterized by involuntary unilateral contractions of the muscles innervated by the ipsilateral facial nerve, usually starting around the eyes before progressing inferiorly to the cheek, mouth, and neck. Its prevalence is 9.8 per 100,000 persons with an average age of onset of 44 years. The accepted pathophysiology of HFS suggests that it is a disease process of the nerve root entry zone of the facial nerve. HFS can be divided into two types: primary and secondary. Primary HFS is triggered by vascular compression whereas secondary HFS comprises all other causes of facial nerve damage. Clinical examination and imaging modalities such as electromyography (EMG) and magnetic resonance imaging (MRI) are useful to differentiate HFS from other facial movement disorders and for intraoperative planning. The standard medical management for HFS is botulinum neurotoxin (BoNT) injections, which provides low-risk but limited symptomatic relief. The only curative treatment for HFS is microvascular decompression (MVD), a surgical intervention that provides lasting symptomatic relief by reducing compression of the facial nerve root. With a low rate of complications such as hearing loss, MVD remains the treatment of choice for HFS patients as intraoperative technique and monitoring continue to improve.
- 1 August 2014
- Published by Elsevier in Neurochirurgie
- Vol. 60 (4) , 184-187
Brainstem melanomas presenting as a cavernous malformation
- 1 August 2014
- Published by Elsevier in Neurochirurgie
- Vol. 60 (4) , 184-187
Brainstem melanomas presenting as a cavernous malformation
- 8 January 2014
- Published by Springer Nature in Current Treatment Options in Cardiovascular Medicine
- Vol. 16 (2) , 1-10
Intra-Arterial Treatment of Acute Ischemic Stroke: The Continued Evolution
The devastation caused by acute ischemic strokes is evident in every intensive care unit across the world. Although there is no doubt that progress has been made in treatment, it has been slow to come. With the emergence of new technologies in imaging, thrombolysis and endovascular intervention, the treatment modalities of acute ischemic stroke will enter a new era. In this review, we present the concept of the seven evolutionary phases in the treatment of acute ischemic stroke to date.
- 8 January 2014
- Published by Springer Nature in Current Treatment Options in Cardiovascular Medicine
- Vol. 16 (2) , 1-10
Intra-Arterial Treatment of Acute Ischemic Stroke: The Continued Evolution
The devastation caused by acute ischemic strokes is evident in every intensive care unit across the world. Although there is no doubt that progress has been made in treatment, it has been slow to come. With the emergence of new technologies in imaging, thrombolysis and endovascular intervention, the treatment modalities of acute ischemic stroke will enter a new era. In this review, we present the concept of the seven evolutionary phases in the treatment of acute ischemic stroke to date.
- 1 September 2013
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 73 (suppl_1) , ons80-ons85
Stenting as Monotherapy for Uncoilable Intracranial Aneurysms
BACKGROUND:. Small, blister-like aneurysms (BLAs), by virtue of their unique morphology, are difficult to treat with conventional modalities. The use o
- 1 September 2013
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 73 (suppl_1) , ons80-ons85
Stenting as Monotherapy for Uncoilable Intracranial Aneurysms
BACKGROUND:. Small, blister-like aneurysms (BLAs), by virtue of their unique morphology, are difficult to treat with conventional modalities. The use o
- 21 April 2013
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 155 (8) , 1565-1569
Resection of lateral temporal lobe arteriovenous malformations
Background Cerebral arteriovenous malformations (AVMs) can be formidable lesions to treat. There are four modalities available for treatment: expectant management, radiosurgery, embolization, and microsurgery. In order to make a decision about treatment, the surgeon must consider the natural history of the lesion versus the rate of treated morbidity and mortality. Characteristics of temporal lobe AVMs such as their location, the potential for deep-seated arterial feeders and deep venous drainage, increase the risk of early clinical onset, hemorrhage, and overall morbidity and mortality (Fleetwood and Steinberg; Lancet 359:863-873, 3) and provide an additional challenge to surgeons attempting to remove the lesion while preserving eloquent local structures. Methods In this paper, we demonstrate our technique for the microsurgical resection of lateral temporal lobe AVMs. In order to maximize access to the lesion for safe resection, a large craniotomy is utilized, with the malformation separated from the MCA feeding arteries and underlying cortex, with care taken not to compromise en passage vessels. The entire nidus is resected and intraoperative angiography confirms appropriate resection. Conclusions Microsurgical resection remains an important part of the treatment paradigm for temporal lobe AVMs. In appropriately selected patients, this can be done with minimal morbidity.
- 21 April 2013
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 155 (8) , 1565-1569
Resection of lateral temporal lobe arteriovenous malformations
Background Cerebral arteriovenous malformations (AVMs) can be formidable lesions to treat. There are four modalities available for treatment: expectant management, radiosurgery, embolization, and microsurgery. In order to make a decision about treatment, the surgeon must consider the natural history of the lesion versus the rate of treated morbidity and mortality. Characteristics of temporal lobe AVMs such as their location, the potential for deep-seated arterial feeders and deep venous drainage, increase the risk of early clinical onset, hemorrhage, and overall morbidity and mortality (Fleetwood and Steinberg; Lancet 359:863-873, 3) and provide an additional challenge to surgeons attempting to remove the lesion while preserving eloquent local structures. Methods In this paper, we demonstrate our technique for the microsurgical resection of lateral temporal lobe AVMs. In order to maximize access to the lesion for safe resection, a large craniotomy is utilized, with the malformation separated from the MCA feeding arteries and underlying cortex, with care taken not to compromise en passage vessels. The entire nidus is resected and intraoperative angiography confirms appropriate resection. Conclusions Microsurgical resection remains an important part of the treatment paradigm for temporal lobe AVMs. In appropriately selected patients, this can be done with minimal morbidity.
- 1 April 2013
- Published by Elsevier in Neurochirurgie
- Vol. 59 (2) , 69-74
Type I spinal arteriovenous fistulae exception: A case for reclassification
- 1 April 2013
- Published by Elsevier in Neurochirurgie
- Vol. 59 (2) , 69-74
Type I spinal arteriovenous fistulae exception: A case for reclassification